January 26, 2015 10:44 PM ET


Company Overview of OsteoGeneX Inc.

Company Overview

OsteoGeneX Inc. engages in the research and development of small molecule therapeutics focusing on sclerostin and Wnt modulators in the United States. It focuses on developing drug candidates for the treatment of osteoporosis, synthetic bone grafts, and cancer. The company was founded in 2006 and is based in Kansas City, Kansas.

3800 Cambridge Street

Kansas City, KS 66160

United States

Founded in 2006





Key Executives for OsteoGeneX Inc.

Chief Financial Officer
Chairman of the Scientific Advisory Board and Chief Medical Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
IsoRay Medical, Inc. United States
Daiichi Sankyo, Inc. United States
Neuera Pharmaceuticals, Inc. United States
Tetra Discovery Partners LLC United States
Parenta Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OsteoGeneX Inc., please visit www.osteogenex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.